Israeli advance in stem cell tech

Hadassah breakthrough to produce large number of human embryonic stem cells.

March 28, 2010 21:44
1 minute read.
Prof. Benjamin Reubinoff

Prof. Benjamin Reubinoff 311. (photo credit: courtesy)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

A new technology developed at Hadassah University Medical Center has made it possible to produce large amounts of human embryonic stem cells for industry and research by growing them in suspension.

Until now, hESCs – which have the potential of ripening into any other type of body cells for repair of tissues and organs – have been created in small numbers.

Be the first to know - Join our Facebook page.

Called a “breakthrough” in hESC technology, the research was just published in the prestigious science journal Nature Biotechnology. The article, titled “Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension,” was written by Dr. Debora Steiner as part of her post-doctoral work under the direction of Prof. Benjamin Reubinoff, both of Hadassah’s Human Embryonic Stem Cell Research Center, with participation by other Hadassah colleagues.

HESC research has been stymied by the fact that it has, until now, been difficult to make large amounts of them. Conventionally, they have been cultured as colonies consisting of one cell layer attached to a flat “bed” of chemicals or nutrients. The involved a great deal of work, and the number of hESCs produced was limited.

It was thought that propagation of hESCs in a suspension (a mixture in which fine particles are suspended in a fluid where they are supported by buoyancy) was impossible because under these conditions, the cells would stop multiplying and instead undergo uncontrolled ripening into various types of cells.

But the Hadassah researchers developed unique conditions that made it possible for the cells to multiply significantly in suspension without differentiating into specific cell types. By changing the conditions of the culture, they showed that they could control the ripening of hESC clusters in suspension into neural spheres. Thus instead of being grown on beds in one layer, the stem cells could be cultivated in large vats with precise, computerized monitoring of growth conditions.

Related Content

[illustrative photo]
September 24, 2011
Diabetes may significantly increase risk of dementia